Harmony Biosciences Management Inc
General
Total Cases1
Active Cases1
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/31/25 | WAIVER OF SERVICE returned executed by Harmony Biosciences, LLC, Harmony Biosciences Management, Inc., Bioproject Societe Civile de Recherche, Bioprojet Pharma SAS: For Lupin Pharmaceuticals, Inc. waiver sent on 1/27/2025, answer due 3/28/2025. (Tigan, Jeremy) (Entered: 01/31/2025) | |
| 01/31/25 | WAIVER OF SERVICE returned executed by Harmony Biosciences, LLC, Harmony Biosciences Management, Inc., Bioproject Societe Civile de Recherche, Bioprojet Pharma SAS: For Lupin Limited waiver sent on 1/27/2025, answer due 3/28/2025. (Tigan, Jeremy) (Entered: 01/31/2025) | |
| 01/29/25 | Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (rjb) (Entered: 01/29/2025) | |
| 01/24/25 | Summons Issued as to Lupin Limited on 1/24/2025; Lupin Pharmaceuticals, Inc. on 1/24/2025. (Attachments: # [1] Summons Issued)(mpb) (Entered: 01/24/2025) | |
| 01/24/25 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bioproject Societe Civile de Recherche for Bioprojet Pharma SAS filed by Bioprojet Pharma SAS, Bioproject Societe Civile de Recherche. (mpb) (Entered: 01/24/2025) | |
| 01/24/25 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Harmony Biosciences Holdings, Inc. for Harmony Biosciences Management, Inc., Harmony Biosciences, LLC filed by Harmony Biosciences Management, Inc., Harmony Biosciences, LLC. (mpb) (Entered: 01/24/2025) | |
| 01/24/25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,947 B2; 8,207,197 B2. (mpb) (Entered: 01/24/2025) | |
| 01/24/25 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/13/2024. Date of Expiration of Patent: U.S. Patent No. 8,486,947 expires on September 26, 2029; U.S. Patent No. 8,207,197 expires on March 7, 2030.Thirty Month Stay Deadline: 6/13/2027. (mpb) (Entered: 01/24/2025) | |
| 01/24/25 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 01/24/2025) | |
| 01/24/25 | COMPLAINT for Patent Infringement against Lupin Limited, Lupin Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4598394) - filed by Harmony Biosciences, LLC, Harmony Biosciences Management, Inc., Bioproject Societe Civile de Recherche, Bioprojet Pharma SAS. (Attachments: # [1] Exhibits A-B, # [2] Civil Cover Sheet)(mpb) (Entered: 01/24/2025) |